Eledon Pharmaceuticals

0 followers


Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.

Industries

Headquarters

Stage

Employees

Links

Org chart

David-Alexandre C. Gros
Chief Executive Officer & Director

David-Alexandre C. Gros

Collapse
Steven Perrin
President And Chief Scientific Officer
Paul Little
Chief Financial Officer
David Hovland
Chief Regulatory Officer
Bryan Smith
General Counsel, Chief Compliance Officer, & Corporate Secretary
John Herberger
Vice President Technical Operations
Carmen Mak
VP, Biometrics
Eliezer Katz
Chief Medical Officer